Under normal iron concentration (no extra iron supplementation), prolactin positively impacted the iron uptake in mammary cancer cells while prolactin treatment might protect EO771 cells from iron overload in the presence of excess iron regardless of the redox state of iron (Supplementary Figure S1A with excess ferrous iron and Supplementary Figure S1B with excess ferric iron). Here, PRL is linked to breast cancer.